Training activity information
Details
Select appropriate platelet units for patients requiring HLA/HPA selected platelets
Type
Developmental training activity (DTA)
Evidence requirements
Evidence the activity has been undertaken by the trainee.
Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.
An action plan to implement learning and/or to address skills or knowledge gaps identified.
Considerations
- Local procedures
- Internal quality controls and external quality assessment measures appropriate to the methods used
- Local protocols for the selection of HLA and/or HPA compatible platelets
- Indications for platelet transfusion
- Matching algorithms
- Pre and post transfusion monitoring
Reflective practice guidance
The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.
Before action
- What is the objective of selecting appropriate platelet units for these patients?
- How does this contribute to effective platelet transfusions and preventing refractoriness?
- What is your understanding of HLA and HPA antigens and their relevance in platelet transfusion?
- What are the criteria for selecting HLA/HPA matched platelets?
- Are you familiar with the laboratory procedures and databases used for identifying suitable units?
- What specific skills in matching patient HLA/HPA types with available platelet units do you hope to develop?
- How will you learn to navigate the complexities of identifying suitable units, especially for patients with multiple antibodies?
- What factors (e.g., availability, urgency) might influence the selection process?
- What patient information will you need (e.g., HLA and HPA typing, antibody screening results)? Will you familiarise yourself with the platelet inventory and the procedures for selecting matched units in your laboratory?
- Will you discuss the selection process with a senior colleague?
- How do you feel about the responsibility of ensuring patients receive appropriate blood products?
In action
- What are the specific HLA and/or HPA requirements for the patient needing selected platelets?
- How are you searching or screening the available platelet inventory to identify suitable units?
- What criteria are you using to determine a match (e.g., antigen compatibility, antibody negativity)?
- Are you considering any other factors, such as blood group compatibility or unit age?
- What steps are you taking to ensure the selected units meet the patient’s specific requirements?
- Are you finding the information on platelet units readily accessible and easy to interpret?
- How effective are your strategies for matching patient requirements with available units?
- What challenges are you encountering if there are limited suitable units available?
- What are you learning about the logistical considerations and potential difficulties in providing HLA/HPA selected platelets?
- If a fully matched unit is not available, are you considering alternative options or discussing the situation with a senior colleague?
- Are you ensuring accurate documentation of the selected units and the rationale for their selection?
- Are you aware of and adhering to local and national guidelines for the provision of selected platelets?
On action
- What were the specific HLA and/or HPA requirements for the patient(s) you considered?
- How did you identify and select appropriate platelet units based on these requirements?
- What challenges did you encounter in finding suitable units?
- What documentation or processes were involved in the selection process?
- What are the indications for HLA and HPA selected platelet transfusions?
- How are HLA and HPA matched platelet units identified and made available?
- What are the logistical considerations in providing selected platelet units?
- Did this activity improve your understanding of the importance of accurate patient typing and unit selection?
- How will you approach the selection of HLA/HPA selected platelets in future cases?
- What further knowledge do you need about the inventory management and availability of these specialised products?
- How will you ensure timely and appropriate provision of selected platelet units to patients who need them?
Beyond action
- Have you reviewed the cases where you selected appropriate platelet units for patients requiring HLA/HPA selected platelets?
- Have you considered the clinical outcomes of these transfusions (if known) and whether the selected units were effective?
- Have you reflected on any challenges encountered during the selection process (e.g., availability of units, complex patient requirements)?
- Has this training activity enhanced your practical knowledge of HLA and HPA antigens and their relevance in platelet transfusion?
- How has this experience improved your ability to navigate databases and selection algorithms to identify appropriate platelet units for specific patient needs?
- Has it increased your awareness of the logistical considerations involved in providing specialised blood products?
- How has this activity contributed to your ability to assess the suitability of patients for HLA/HPA selected platelets and identify compatible platelet units?
- Will the skills and knowledge gained in this training activity be essential for future work involving the provision of specialised blood components?
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 2 |
Outcome
Interpret and report tests across the range of techniques applied and provide appropriate clinical advice for solid organ transplant. |
| # 5 |
Outcome
Assess the suitability of patients for HLA/HPA selected platelets and identify compatible platelet units. |
| # 7 |
Outcome
Practice in accordance with quality management and accreditation standards. |